Indonesia diagnostic labs market stood at USD 1997.95 Million in 2021 and is expected to reach a
CAGR of 7.84% during the forecast period. This can be attributed to the growing
prevalence of various communicable and non-communicable diseases in the
country. Additionally, the growing geriatric population is susceptible to
various diseases and requires regular diagnostic checkups for disease diagnosis
and treatment, increasing the demand for diagnostic labs. Besides, growing healthcare
awareness among the population related to preventive healthcare and early
disease diagnosis and treatment is further expected to create lucrative
opportunities for market growth.
Growing Prevalence of Diseases
Bacterial, parasitic, and viral gastroenteritis, typhoid fever, and
viral hepatitis, among others, are some of Indonesia's most observed diseases
requiring accurate diagnosis and treatment. Similarly, the country's prevalence
of chronic diseases such as cancer,
diabetes, cardiovascular diseases,
among others, has significantly increased in recent years. According to Global
Cancer Observatory, in 2020, Indonesia reported 396,914 new cancer cases, with breast
cancer, cervix uteri, lung
cancer, colorectum, and liver cancer being the most prevalent. This has
significantly increased the demand for disease diagnosis to provide effective
and timely treatment, thereby fueling the growth of diagnostic labs in the
country.
Growing Healthcare Expenditure
The improving healthcare infrastructure across Indonesia will increase
the number of hospital establishments and diagnostic laboratories across the
country. Additionally, the Indonesian government continuously invests in
upgrading the existing hospitals' infrastructure. Also, the healthcare
expenditure in Indonesia is constantly increasing. It was about 2.9% of the
country's GDP in 2019, which is expected to increase in the coming years. This,
in turn, will create new opportunities for hospital-based diagnostic labs.
Growing Geriatric Population
In Indonesia, 9.6% of the country’s total population was 60 and above
in 2019. The increase in the elderly population has further increased the demand
for the diagnosis of diseases and disorders. The elderly population is highly
susceptible to diseases requiring several diagnostic tests to diagnose the
disease condition and provide accurate treatment. This, in turn, is expected to
create lucrative opportunities for the growth of the Indonesia diagnostic labs
market during the forecast period. Taking the advantage of prevailing geriatric
population and the diseases related to them, companies have introduced multiple
services in terms of many packages as per the customers’ suitability and
requirements.
DOWNLOAD FREE SAMPLE REPORT
Market Segmentation
The Indonesia diagnostic labs market is
segmented based on provider type, test type, end user,
and regions distribution. Based on provider type, the market can be split among
hospital based diagnostic labs,
diagnostic chains, and stand-alone diagnostic labs. Based on test type, the
market can be divided into pathology and radiology. In terms of end users, the market
can be categorized into referrals, walk-ins, and corporate clients.
Company Profiles
Laboratorium
Klinik CITO Indraprasta Semarang (CITO), Bio Medika Laboratorium Klink Utama, Prodia
Clinical Laboratory, PT Kimia Farma Diagnostika, Pramita Lab, Laboratorium
Parahita Diagnostic Center, PT Indec Diagnostics, Klinik & Laboratorium
Klinik Ultra Medica, PT Prima Medika Laboratories, Laboratorium Klinik ABC
Pusat, among others. Various companies operating in the market are following
strategies such as offering discounts & offers, packages, among others to
attract more customers.
Attribute
|
Details
|
Market size value in 2021
|
USD 1997.95 Million
|
Revenue Forecast in 2027
|
USD 3177.31
Million
|
Growth Rate
|
7.84%
|
Base Year
|
2021
|
Historical Years
|
2017 – 2021
|
Estimated Year
|
2022
|
Forecast Period
|
2023 – 2027
|
Quantitative Units
|
Revenue
in USD Million, and CAGR for 2017-2021 and 2022E-2027F
|
Report Coverage
|
Revenue forecast, company share, competitive landscape, growth
factors, and trends
|
Segments Covered
|
·
Provider Type
·
Test Type
·
End User
|
Regional Scope
|
Sumatra, Java, Celebes; Borneo; Rest of Indonesia
|
Key Companies Profiled
|
Laboratorium
Klinik CITO Indraprasta Semarang (CITO), Bio Medika Laboratorium Klink Utama,
Prodia Clinical Laboratory, PT Kimia Farma Diagnostika, Pramita Lab,
Laboratorium Parahita Diagnostic Center, PT Indec Diagnostics, Klinik &
Laboratorium Klinik Ultra Medica, PT Prima Medika Laboratories, Laboratorium
Klinik ABC Pusat
|
Customization Scope
|
10% free report customization with purchase. Addition or alteration to
country, regional & segment scope.
|
Pricing and Purchase Options
|
Avail
customized purchase options to meet your exact research needs. Explore purchase options
|
Delivery Format
|
PDF and Excel through Email (We can also
provide the editable version of the report in PPT/pdf format on special
request)
|
Report Scope:
In this report, Indonesia diagnostic labs market has
been segmented into following categories, in addition to the industry trends
which have also been detailed below:
- Indonesia Diagnostic Labs Market, By Provider Type:
- Hospital Based Diagnostic Labs
- Diagnostic Chains
- Stand Alone Diagnostic Labs
- Indonesia Diagnostic Labs Market, By Test Type:
- Indonesia Diagnostic
Labs Market, By End User:
- Walk-ins
- Referrals
- Corporate Clients
- Indonesia Diagnostic Labs Market, By Region:
- Sumatra
- Java
- Celebes
- Borneo
- Rest of
Indonesia
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in Indonesia diagnostic
labs market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company
Information
Detailed analysis and
profiling of additional market players (up to five).